Biobizkaia
Ikerketa zentroa
Hacettepe University
Ankara, TurquíaHacettepe University-ko ikertzaileekin lankidetzan egindako argitalpenak (47)
2024
-
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom
Journal of medical economics, Vol. 27, Núm. 1, pp. 109-125
-
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders
Ocular Immunology and Inflammation
-
Recovery course of persistent posterior subretinal fluid after successful repair of rhegmatogenous retinal detachment
European Journal of Ophthalmology, Vol. 34, Núm. 4, pp. 1217-1227
-
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study
Brain, Vol. 147, Núm. 8, pp. 2652-2667
2023
-
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project
Frontiers in Medicine, Vol. 10
-
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis
JAMA Neurology, Vol. 80, Núm. 7, pp. 702-713
-
Comparative effectiveness in multiple sclerosis: A methodological comparison
Multiple Sclerosis Journal, Vol. 29, Núm. 3, pp. 326-332
-
Disability accrual in primary and secondary progressive multiple sclerosis
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 94, Núm. 9, pp. 707-717
-
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
Multiple sclerosis (Houndmills, Basingstoke, England), Vol. 29, Núm. 7, pp. 875-883
-
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial
Journal of neurology, neurosurgery, and psychiatry, Vol. 94, Núm. 12, pp. 1004-1011
-
Respective roles of non-pharmaceutical interventions in bronchiolitis outbreaks: an interrupted time-series analysis based on a multinational surveillance system
The European respiratory journal, Vol. 61, Núm. 2
-
Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey
Pediatric Nephrology, Vol. 38, Núm. 9, pp. 3035-3042
-
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable
Brain : a journal of neurology, Vol. 146, Núm. 11, pp. 4633-4644
-
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis
European Journal of Neurology, Vol. 30, Núm. 4, pp. 1014-1024
2022
-
Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study
Neurology, Vol. 98, Núm. 24, pp. E2401-E2412
-
FXR1 -related congenital myopathy: expansion of the clinical and genetic spectrum
Journal of Medical Genetics, Vol. 59, Núm. 11, pp. 1069-1074
-
It is time to define an organizational model for the prevention and management of infections along the surgical pathway: a worldwide cross-sectional survey
World Journal of Emergency Surgery, Vol. 17, Núm. 1
-
Parathyroid hormone and phosphate homeostasis in patients with Bartter and Gitelman syndrome: an international cross-sectional study
Nephrology Dialysis Transplantation, Vol. 37, Núm. 12, pp. 2474-2486
-
Presentations of children to emergency departments across Europe and the COVID-19 pandemic: A multinational observational study
PLoS medicine, Vol. 19, Núm. 8, pp. e1003974
2021
-
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study
Journal of Infection, Vol. 83, Núm. 3, pp. 306-313